Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Butterworth

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Molecular Biology of the Cell|February 9, 2007
Death receptor-induced apoptosis reveals a novel interplay between the chromosomal passenger complex and CENP-C during interphaseAlison J Faragher, Xiao-Ming Sun, Michael Butterworth, et al.
Cell Death and Differentiation|September 7, 2018
BH3-only proteins are dispensable for apoptosis induced by pharmacological inhibition of both MCL-1 and BCL-X<sub>L</sub>Georgia Greaves, Mateus Milani, Michael Butterworth, et al.
Journal of Visualized Experiments : Jove|February 22, 2021
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in PatientsGiuditta Viticchié, Ian Powley, Constantinos Demetriou, et al.
Haematologica|April 10, 2010
Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cellsMaria Baou, Susan L Kohlhaas, Michael Butterworth, et al.
Plos Computational Biology|January 4, 2013
Novel modeling of combinatorial miRNA targeting identifies SNP with potential role in bone densityClaudia Coronnello, Ryan Hartmaier, Arshi Arora, et al.
Cell Death & Disease|December 6, 2019
Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neckRachel J Carter, Mateus Milani, Michael Butterworth, et al.
Scientific Reports|June 4, 2024
An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapyConstantinos Demetriou, Naila Abid, Michael Butterworth, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molecular Biology of the Cell|February 9, 2007
Death receptor-induced apoptosis reveals a novel interplay between the chromosomal passenger complex and CENP-C during interphaseAlison J Faragher, Xiao-Ming Sun, Michael Butterworth, et al.
Cell Death and Differentiation|September 7, 2018
BH3-only proteins are dispensable for apoptosis induced by pharmacological inhibition of both MCL-1 and BCL-X<sub>L</sub>Georgia Greaves, Mateus Milani, Michael Butterworth, et al.
Journal of Visualized Experiments : Jove|February 22, 2021
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in PatientsGiuditta Viticchié, Ian Powley, Constantinos Demetriou, et al.
Haematologica|April 10, 2010
Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cellsMaria Baou, Susan L Kohlhaas, Michael Butterworth, et al.
Plos Computational Biology|January 4, 2013
Novel modeling of combinatorial miRNA targeting identifies SNP with potential role in bone densityClaudia Coronnello, Ryan Hartmaier, Arshi Arora, et al.
Cell Death & Disease|December 6, 2019
Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neckRachel J Carter, Mateus Milani, Michael Butterworth, et al.
Scientific Reports|June 4, 2024
An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapyConstantinos Demetriou, Naila Abid, Michael Butterworth, et al.
Pageof 2